The Clorox Company (NYSE:CLX) Holdings Decreased by Trust Co. of Vermont

Trust Co. of Vermont reduced its holdings in The Clorox Company (NYSE:CLX) by 2.6% in the 4th quarter, Holdings Channel reports. The fund owned 21,089 shares of the company’s stock after selling 563 shares during the period. Trust Co. of Vermont’s holdings in Clorox were worth $3,425,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of CLX. Dimensional Fund Advisors LP boosted its stake in shares of Clorox by 11.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company’s stock valued at $109,483,000 after buying an additional 85,529 shares during the period. Moors & Cabot Inc. raised its position in Clorox by 31.9% during the second quarter. Moors & Cabot Inc. now owns 3,746 shares of the company’s stock valued at $511,000 after acquiring an additional 905 shares in the last quarter. Mercer Global Advisors Inc. ADV lifted its stake in Clorox by 7.7% in the second quarter. Mercer Global Advisors Inc. ADV now owns 13,768 shares of the company’s stock valued at $1,879,000 after acquiring an additional 980 shares during the last quarter. Elo Mutual Pension Insurance Co grew its position in Clorox by 13.4% in the second quarter. Elo Mutual Pension Insurance Co now owns 11,609 shares of the company’s stock worth $1,584,000 after acquiring an additional 1,375 shares in the last quarter. Finally, Hsbc Holdings PLC raised its holdings in shares of Clorox by 23.4% during the 2nd quarter. Hsbc Holdings PLC now owns 499,102 shares of the company’s stock valued at $68,124,000 after purchasing an additional 94,807 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX stock traded down $0.16 during mid-day trading on Friday, reaching $160.31. The stock had a trading volume of 937,465 shares, compared to its average volume of 960,748. The firm has a market cap of $19.84 billion, a PE ratio of 55.86, a P/E/G ratio of 2.90 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The firm’s 50 day simple moving average is $164.35 and its 200 day simple moving average is $156.20.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.49 EPS. On average, analysts forecast that The Clorox Company will post 6.87 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CLX. Evercore ISI decreased their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and upped their price target for the stock from $155.00 to $157.00 in a research note on Tuesday, January 7th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Finally, Barclays reduced their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research note on Friday. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, Clorox presently has an average rating of “Hold” and an average target price of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.